Welcome to our dedicated page for CORPAY SEC filings (Ticker: CPAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CORPAY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CORPAY's regulatory disclosures and financial reporting.
Netto Armando Lins reported acquisition or exercise transactions in this Form 4 filing.
CORPAY, INC. granted Group President Brazil & US Vehicle Payments Armando Lins Netto three tranches of performance-based restricted stock units totaling 28,213 units. Each unit represents a contingent right to one share of CPAY common stock. The tranches cover 9,405, 9,404 and 9,404 units that may be earned only if the CPAY share price equals or exceeds $425.00, $450.00 and $475.00, respectively, on five separate trading days before August 31, 2028, and remain subject to the company’s equity compensation plan and award agreement terms.
Clarke Ronald reported acquisition or exercise transactions in this Form 4 filing.
Corpay, Inc. reported that CEO and Chairman Ronald Clarke received grants of three tranches of 100,000 performance-based restricted stock units, each settled in common stock. Each tranche is earned only if CPAY’s closing price equals or exceeds $425, $450, or $475 on five separate trading days before August 31, 2028, with vesting of earned units subject to the company’s equity compensation plan and related award agreements.
Corpay, Inc. reports that its Compensation Committee approved special grants of performance-based restricted stock units (PSUs) under the Amended and Restated 2010 Equity Compensation Plan to Ronald F. Clarke and Armando L. Netto, effective July 22, 2026. Clarke received 300,000 PSUs and Netto received 28,213 PSUs, which are intended to align their compensation with shareholder stock price interests and support retention over the applicable period.
The PSUs have a performance period running from the Grant Date through August 31, 2028. They are earned in tranches upon achievement of stock price hurdles: 100,000 PSUs for Clarke and 9,405 for Netto if the closing price equals or exceeds $425.00 on five separate trading days during the period; additional 100,000 and 9,404 PSUs at $450.00; and the remaining 100,000 and 9,404 PSUs at $475.00, with vesting of earned PSUs further subject to the Plan and related award agreements.
Corpay CFO Peter Walker reported compensation-related equity activity on July 15, 2026. The company withheld a total of 1,660 shares of common stock at $356.16 per share to cover tax liabilities on vesting awards. He also received 568 vested performance-based shares and a new 938-share performance-based restricted stock award that will vest in thirds through 2028, subject to continued employment; no open-market trades were reported.
Corpay, Inc. executive Armando Lins reported an exercise-and-sell transaction in company stock. On June 15, 2026, he exercised employee stock options to acquire a total of 70,476 shares of Corpay common stock and, on the same date, completed an open-market sale of 70,476 common shares at an average price of $352.1308 per share.
Following these transactions, Lins holds 11,274 Corpay common shares directly. The derivative summary in this filing shows no remaining employee stock options, indicating that the reported option positions were fully exercised.
Corpay, Inc. director Steven T. Stull reported an open-market sale of 1,000 shares of Common Stock at $360.78 per share on June 2, 2026. After this transaction, he directly holds 28,241 Corpay shares. The filing also notes 6,247 shares held indirectly "by Funds," over which he has shared voting power through Advantage Capital Financial Company, LLC and related entities, while disclaiming beneficial ownership beyond his pecuniary interest.
CPAY notice of proposed sale: an officer reported multiple dispositions of Common Stock and listed several option exercises under a registered plan.
Armando Netto reported sales of 4,560, 2,694, 14,089, and 418 shares on 05/27/2026–06/11/2026. The filing also shows planned option exercises and cash exercises dated 06/15/2026 totaling individual lots of 20,000, 513, 18,352, 18,352, and 13,259 shares.
CORPAY, INC. Group President Armando Lins Netto sold 4,560 shares of Common Stock in an open-market transaction at $351.6025 per share. After this sale, he directly holds 11,274 shares, so the transaction reduces but does not eliminate his personal equity stake.
Armando Netto reported sale of Common Stock under Rule 144. The filing lists three dispositions on 05/27/2026, 05/28/2026, and 05/29/2026 showing 418, 14,089, and 2,694 shares sold respectively, with proceeds recorded for each sale. The filing also lists several restricted stock vesting entries dated in January and February 2025 tied to services rendered.
Corpay, Inc. executive Armando Lins Netto reported selling 17,201 shares of Common Stock in open-market transactions. The sales occurred over three days, with 418 shares sold on May 27, 14,089 shares on May 28, and 2,694 shares on May 29 at prices around $355–$357 per share. After these transactions, he directly holds 15,834 Corpay shares.